Emily Bury: From Emerging Evidence to Better Patient Care at ISTH 2026
Emily Bury, Advanced Nurse Practitioner for Thrombosis at St.Vincent’s Healthcare Group, shared a post on LinkedIn:
“A fantastic few days at ISTH 2026 in Paris, with rich learning, inspiring discussions and valuable opportunities to connect with colleagues from around the world.
It was exciting to see women’s health take centre stage, including the launch of the ‘Women’s Health Hub‘—a significant step towards advancing research, education and equitable care for women with thrombosis and bleeding disorders.
Another key highlight was the continued focus on ‘cancer-associated VTE‘, with the ‘API-CAT trial‘ demonstrating that extended treatment with ‘reduced-dose apixaban’ was non-inferior to the full treatment dose for preventing recurrent VTE, while reducing clinically relevant bleeding.
Delighted to attend alongside Tracy Egan of the Irish Heart Foundation – (supporting Thrombosis patients).
Looking forward to bringing insights from ISTH back to support better patient care.”
Stay updated with Hemostasis Today.
-
Oct 19, 2026, 17:44Paul Riley: Moderating a Webinar on Anticoagulation Monitoring
-
Oct 19, 2026, 16:36Christopher Pittman: Blood Clot Prevention Cannot End at Hospital Discharge
-
Oct 19, 2026, 16:13Javier M. Floren: When Immune Cells Move With Their Environment
-
Oct 19, 2026, 16:04Hussnain Javaid: New EHA Guidelines for HbSC Disease Management
-
Oct 19, 2026, 15:50Deep Madkaiker: A New Academic Opportunity in Transfusion Medicine at ACTREC
-
Oct 19, 2026, 15:19Why Hematologists Should Care About Diminished Ovarian Reserve in SCD – ASH Education
-
Oct 19, 2026, 14:16Hyperfibrinolysis as an Underrecognized Cause of Bleeding
-
Oct 19, 2026, 13:36Shobhna Ladva: Aspen Pharma EME Raises Awareness of Blood Clot Risks During Hormonal Transitions
-
Oct 19, 2026, 13:11Giulia Furnari: Connecting With Global Hematology Experts at IACH 2026